Ortho Clinical Diagnostics Announces Launch of Initial Public Offering
RARITAN, N.J., Jan. 19, 2021 /PRNewswire/ — Ortho Clinical Diagnostics Holdings plc (“Ortho”), the world’s largest pure-play in vitro diagnostics company dedicated to improving and saving lives through innovative laboratory testing and blood-typing solutions, today announced the launch of its initial public offering of its ordinary shares. Ortho is offering 70 million ordinary shares, with the initial public offering price expected to be between $20.00 and $23.00 per share.
Access to content from the Arctic Knowledge Archives is available to Passport holders only.
Arctic Today is a non-profit organization, supported by donations from readers like you. While we strongly believe in giving free access to current news for all readers, we reserve content older than one year for our supporters. All individual contributions of at least $20/month or $150/year will receive a Passport to the Arctic Knowledge Archives. Help us drive the leading non-profit editorial team dedicated to delivering context, information and analysis about events in the Arctic.
Already have a Passport? Sign in
Choose your level of support and unlock your Arctic Today Passport.
- Monthly
- Annually
- Groups & Institutions
Individual Monthly
$20.00
Month
Individual Annual
$150.00
Year
Individual Monthly
$20.00
0
Individual Yearly
$150.00
0
